WELLS FARGO & COMPANY/MN - CITIUS PHARMACEUTICALS INC ownership

CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 74 filers reported holding CITIUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of CITIUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$23,221
-62.4%
33,928
-34.1%
0.00%
Q2 2023$61,771
+970.9%
51,476
+944.1%
0.00%
Q1 2023$5,768
+48.5%
4,930
+0.3%
0.00%
Q4 2022$3,884
-35.3%
4,916
+0.5%
0.00%
Q3 2022$6,000
+20.0%
4,893
-0.1%
0.00%
Q2 2022$5,000
-90.6%
4,900
-83.5%
0.00%
Q1 2022$53,000
-48.5%
29,722
-55.7%
0.00%
Q4 2021$103,000
-92.2%
67,158
-89.6%
0.00%
Q3 2021$1,317,000
+8680.0%
648,600
+14192.6%
0.00%
Q2 2021$15,000
+200.0%
4,538
+66.9%
0.00%
Q1 2021$5,000
+150.0%
2,719
+20.1%
0.00%
Q4 2020$2,0000.0%2,264
+0.7%
0.00%
Q3 2020$2,0000.0%2,248
+6.2%
0.00%
Q2 2020$2,000
-81.8%
2,116
-88.6%
0.00%
Q1 2020$11,000
+450.0%
18,586
+829.3%
0.00%
Q4 2019$2,0000.0%2,0000.0%0.00%
Q3 2019$2,0000.0%2,0000.0%0.00%
Q2 2019$2,000
-33.3%
2,0000.0%0.00%
Q1 2019$3,0002,0000.00%
Other shareholders
CITIUS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Inspire Advisors, LLC 188,796$291,0000.08%
Horst & Graben Wealth Management LLC 75,722$117,0000.03%
Alpine Global Management, LLC 83,475$129,0000.02%
Miller Investment Management, LP 50,000$77,0000.01%
SABBY MANAGEMENT, LLC 30,863$48,0000.01%
WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC 49,075$76,0000.00%
Alberta Investment Management Corp 172,185$265,0000.00%
Syverson Strege & Co 2,145$3,0000.00%
HighTower Advisors, LLC 170,623$263,0000.00%
HRT FINANCIAL LP 90,871$139,0000.00%
View complete list of CITIUS PHARMACEUTICALS INC shareholders